COPENHAGEN, May 13 (Reuters) - Danish pharmaceutical group Lundbeck (LUN.CO) would not be able to buy Irish biotech company Elan (ELN.I) in current market conditions, Lundbeck’s Chief Financial Officer Anders Gotzsche said on Wednesday.
COPENHAGEN, May 13 (Reuters) - Danish pharmaceutical group Lundbeck (LUN.CO) would not be able to buy Irish biotech company Elan (ELN.I) in current market conditions, Lundbeck’s Chief Financial Officer Anders Gotzsche said on Wednesday.
